Țară: Israel
Limbă: engleză
Sursă: Ministry of Health
OLOPATADINE AS HYDROCHLORIDE
NOVARTIS ISRAEL LTD
S01GX09
EYE DROPS
OLOPATADINE AS HYDROCHLORIDE 1 MG/ML
OCULAR
Required
ALCON PHARMACEUTICALS LTD, SWITZERLAND
OLOPATADINE
OLOPATADINE
For the temporary prevention of itching of the eye due to allergic conjunctivitis.
2012-11-30
IF YOU ACCIDENTALLY TOOK A HIGHER DOSAGE, wash the eye thoroughly with warm water. Do not instill any more into the eye until it is time for the next dose. If you took an overdose, or if a child has accidentally swallowed the medicine, refer immediately to a doctor or proceed to a hospital emergency room and bring the package of the medicine with you. IF YOU FORGOT TO TAKE THE MEDICINE at the required time, take a dose as soon as you remember and then return to your normal dosing regimen. However, if it is almost time to take the next dose, skip the forgotten dose and return to your normal dosing regimen at the next administration. Do not take two doses together to compensate for the forgotten dose. Adhere to the treatment regimen as recommended by the doctor. Even if there is an improvement in your health, do not stop treatment with the medicine without consulting the doctor. IF YOU STOP TAKING THE MEDICINE Do not stop taking the medicine without consulting with the doctor. DO NOT TAKE MEDICINES IN THE DARK! CHECK THE LABEL AND THE DOSE EACH TIME YOU TAKE THE MEDICINE. WEAR GLASSES IF YOU NEED THEM. IF YOU HAVE FURTHER QUESTIONS REGARDING USE OF THE MEDICINE, CONSULT THE DOCTOR OR PHARMACIST. 4. SIDE EFFECTS: As with any medicine, use of Patanol may cause side effects in some users. Do not be alarmed by the list of side effects. You may not suffer from any of them. The following side effects were observed with use of Patanol: COMMON SIDE EFFECTS - EFFECTS THAT OCCUR IN 1-10 IN 100 USERS: Eye effects: eye pain, eye irritation, dry eye, an abnormal eye sensation, eye discomfort. General effects: headache, fatigue, dry nose, bad taste in the mouth. UNCOMMON SIDE EFFECTS - EFFECTS THAT OCCUR IN 1-10 IN 1,000 USERS: Eye effects: blurred vision, reduced vision, abnormal vision, corneal disorder, eye surface inflammation with or without eye surface damage, inflammation or infection of the conjunctiva, eye discharge, sensitivity to light, increased tear production, itchiness of the eye, redness of the eye, unusual sensa Citiți documentul complet
PAT API MAY21 V3 EU update SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT PATANOL® 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One mL of solution contains 1 mg olopatadine (as hydrochloride), olopatadine hydrochloride 0.111%. Excipient(s) with known effect: Benzalkonium chloride 0.1 mg/ml. Dibasic sodium phosphate 5 mg/ml (equivalent to 3.35 mg/ml of phosphates) For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Eye drops, solution (ocular). Colourless to pale yellow. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the temporary prevention of itching of the eye due to allergic conjunctivitis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology The dose is one drop of PATANOL in the conjunctival sac of the affected eye(s) twice daily (8 hourly). Treatment may be maintained for up to four months, if considered necessary. Use in elderly No dosage adjustment in elderly patients is necessary. Paediatric patients PATANOL may be used in paediatric patients three years of age and older at the same dose as in adults. The safety and efficacy of PATANOL in children aged under 3 years has not been established. No data are available. Use in hepatic and renal impairment Olopatadine in the form of eye drops (PATANOL) has not been studied in patients with renal or hepatic disease. However, no dosage adjustment is expected to be necessary in hepatic or renal impairment (see section 5.2). Method of administration For ocular use only. PAT API MAY21 V3 EU update After the bottle cap is removed, if the tamper evident snap collar is loose, remove before using the product. To prevent contamination of the dropper tip and solution, care must be taken not to touch the eyelids, surrounding areas, or other surfaces with the dropper tip of the bottle. Keep the bottle tightly closed when not in use. In case of concomitant therapy with other topical ocular medicines, an interval of five minutes should be allowed between successive applications. Eye ointments should be administered last. 4.3 CO Citiți documentul complet